This page was last updated on 10/01/2020. Please check back frequently for updates.

How should care for patients with cancer types (e.g. breast cancer, lung cancer) be affected?

This section provides links to disease-specific information that has been released by other organizations.

Breast cancer

  • The American Society of Breast Surgeons has published information on triage, prioritization, appropriate care, and reentry into therapy for patients with breast cancer available on its COVID-19 resource center.
  • The American College of Surgeons has published information on triage of patients with breast cancer for surgery. 
  • An American multi-organizational panel has published recommendations on the triage, prioritization and treatment of breast cancer (Dietz et al, Breast Cancer Res Treat). An international group has also published recommendations on the same topic (Curigliano et al, Breast)
  • An American group from Johns Hopkins Women’s Malignancies Program has published information on care for patients with breast cancer (Sheng et al, JCO Oncol Pract)
  • The European Society of Medical Oncology (ESMO) has published information on care for patients with breast cancer (de Azambuja et al, ESMO Open)

Gastrointestinal cancers

Genitourinary cancers

  • Canadian recommendations on prioritizing systemic therapy in patients with genitourinary malignancies has been published.  (Lalani et al, Can Urol Assoc J)
  • An editorial in European Urology has presented considerations for the triage of patients for urological surgery, including patients with genitourinary malignancies (Stresland et al, Eur Urol
  • The Canadian Urologic Oncology Group and the Canadian Urological Association have published guidelines for care of patients with prostate cancer (Kokorovic et al, Can Urol Assoc J)
  • Wallis et al, Eur Urol conducted a systematic review that provides information on the potential risks associated with delaying therapy for various genitourinary cancers.
  • A British group has published information on care for patients with urothelial cancer (Patel et al, Clin Oncol (R Coll Radiol))
  • The German Cancer Society has published information on systemic therapy for patients with advanced/metastatic renal cell carcinoma during the pandemic (Ivanyi et al, J Cancer Res Clin Oncol)

Gynecological cancers

  • Uwins et al, Int J Gynecol Cancer published a synthesis of recommendations for the care of patients with gynecological cancers during the pandemic issued by more than 25 different governmental and professional organizations.
  • The editors of the International Journal of Gynecological Cancer have published information for management of patients with those cancers. (Ramirez et al, Int J Gynecol Cancer)
  • The National College of French Gynecologists and Obstetricians have published recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic (Akladios et al, J Gynecol Obstet Hum Reprod
  • An American multi-institutional group has published recommendations for anti-cancer therapy and surveillance for recurrence of patients with gynecological cancers (Pothuri et al, Gynecol Oncol)
  • ESMO has published information on management of patients with gynecological malignancies (Columbo et al, ESMO Open)

Head and neck cancer

  • The French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL) and French Society of Head and Neck Carcinology (SFCCF) have published consensus recommendations on the management of patients requiring head and neck cancer surgery (Fakhry et al, Eur Ann Otorhinolaryngol Head Neck Dis). Similar recommendations have been published by the Canadian Association of Head and Neck Surgical Oncology (O’Connell et al, J Otolaryngol Head Neck Surg)
  • The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium has published detailed cancer-site specific recommendations for triage for head and neck cancer surgery (Head et al, Head Neck)

Hematological malignancy

  • The American Society of Hematology has released information related to several different malignancies.
  • The Seattle Cancer Care Alliance has published guidance on managing patients with hematological malignancies (Percival et al, JCO Oncol Pract)
  • Multiple Myeloma
    • An international group of authors has published recommendations on the care of older patients with multiple myeloma (Mian et al, J Geriatr Oncol)
    • A group from the Mayo Clinic has published recommendations regarding management of patients with multiple myeloma (Al Saleh, Acta Haematol)
  • A Brazilian task force has published recommendations on the management of patients with lymphoid malignancies (Perini et al, Hematol Transfus Cell Ther)
  • The French Society for the fight against Cancers and Leukemias in children and adolescents has published information on management of young patients with acute lymphoblastic leukemia (Baruchel et al, Bull Cancer)
  • An Australia/New Zealand consensus statement on care for patients with lymphoma, chronic lymphocytic leukemia and myeloma is available (Di Ciaccio et al, Intern Med J)

Hepatocellular carcinoma

  • The International Liver Cancer Association (ILCA) has released information related to are of patients with hepatocellular carcinoma.
  • An international group has published recommendations on the management of primary hepatic malignancy (Barry et al, Lancet Gastroenterol Hepatol)

Lung cancer


  • The American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Tumor Section and the Society for Neuro-Oncology (SNO) have published general information on care of patients with brain tumors and brain metastases (Ramakrishna et al, J Neurooncol)
  • Information specific to management of patients with glioma has been published by two international multi-disciplinary groups (Mohile et al, Neuro OncolBernhardt et al Neuro Oncol)


  • The Sarcoma European and Latin American Network has published information on prioritization of care for patients with various forms of sarcoma (Martin Broto et al, Oncologist)

Skin cancer and cutaneous lymphona


Multiple cancer types

Subpopulation-specific Information: Is there any information specific to subpopulations of patients with cancer?

Elderly Patients​

Pediatric Patients

  • A multi-organizational group has published recommendations on care for pediatric patients (Sullivan et al, Pediatr Blood Cancer)
  • The International Late Effects of Childhood Cancer Guideline Harmonization Group has published information on risk factors and care for survivors of childhood, adolescent, and young adult onset cancer (Verbruggen et al, Pediatr Blood Cancer)


Answers to questions about COVID-19 published herein are provided by the American Society of Clinical Oncology, Inc. (“ASCO”) for voluntary, informational use by providers in the rapidly evolving novel coronavirus crisis. This information does not constitute medical or legal advice, is not intended for use in the diagnosis or treatment of individual conditions, does not endorse products or therapies, recommend or mandate any particular course of medical care, and is not a statement of the standard of care. New evidence may emerge between the time information is developed and when it is published or read. The information is not comprehensive or continually updated. This information is not intended to substitute for the independent professional judgment of the treating provider in the context of treating the individual patient. ASCO provides this information on an “as is” basis, and makes no warranty, express or implied, regarding the information. ASCO specifically disclaims any warranties of merchantability or fitness for a particular use or purpose. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions. Use of the information is subject to the complete ASCO website Terms of Use